Uplift (engot-ov67/gog-3048) a pivotal cohort of the xmt-1536-1 trial of upifitamab rilsodotin (xmt-1536; upri), a napi2b-directed antibody drug conjugate (adc) in platinum-resistant ovarian cancer

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER(2022)

引用 0|浏览13
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要